Skip to content
Finance Investment

NEW DATA REVEALS RECORD CRYPTO ADOPTION IN AUSTRALIA AMID SHIFTING GLOBAL LANDSCAPE

Independent Reserve 2 mins read
  • Record high adoption, with almost a third (32.5%) of Aussies currently owning or having owned cryptocurrency.
  • 95% of Australians are aware of at least one cryptocurrency.
  • A further 14.3% wanted to invest in crypto but refrained due to economic concerns.
  • 42.9% of Australians believe that cryptocurrency will be widely accepted by people and businesses in the future

More Australians than ever before are embracing cryptocurrencies the 2025 Independent Reserve Cryptocurrency Index (IRCI) reveals.

“The findings in our sixth annual IRCI clearly show that Australia’s crypto market is coming into its own. Adoption is growing, investment strategies are evolving, and seasoned investors are seeing better profits,” said Independent Reserve CEO, Adrian Przelozny.

“With a record 32.5% of Australians currently owning or having owned crypto, Bitcoin remains the most popular choice, held by 70% of investors.”

Despite economic uncertainties, 57.3% of Australian crypto investors reported making a profit, and 20.5% are investing $500 or more each month, indicating strong confidence in the sector.

However, 14.3% of Australians reported they wanted to invest in crypto but were deterred by the economic climate. Meanwhile, 42.9% of Australians believe that cryptocurrency will be widely accepted by people and businesses in the future, with 73.4% considering Bitcoin as money, a store of value, or an investment asset.

“Globally, with Donald Trump's election as President of the United States, there is widespread anticipation that his pro-crypto policies will foster innovation and broader adoption of digital assets, and we’re seeing current pricing reflect that global optimism,” he said.

31% of IRCI respondents believe that Trump is good for crypto, compared to just 8% who think he’s bad for the sector. The majority, however, remain neutral, indicating widespread uncertainty about the President’s potential influence.

“Locally, while the sector is experiencing robust growth, challenges in regulatory clarity and market volatility persist. The actions of traditional financial institutions, such as banks blocking or delaying crypto investment activities, highlight the need for clear and supportive regulation to ensure the sector’s legitimacy and continued growth.

Almost one in five investors (19.3%) said their bank had prevented them from buying crypto or delayed sending money to a crypto exchange.

“The 2025 IRCI findings reflect Australia’s maturing crypto market. As the industry navigates the complex interplay of regulation, innovation, and adoption, its potential to reshape the traditional financial landscape remains strong,” said Przelozny.

 

To read the full report visit: https://www.independentreserve.com/blog/news/australian-independent-reserve-cryptocurrency-index-irci-2025 

 


About us:

ABOUT THE IRCI

Now in its sixth year, the Independent Reserve Cryptocurrency Index (IRCI) provides an annual snapshot of cryptocurrency adoption, awareness, and sentiment in Australia. It is an annual cross-sectional survey of over 2,000 Australians conducted by PureProfile. It is a sample of everyday Australians, reflecting the gender, age, and geographic distribution of the nation. The IRCI aims to inform industry stakeholders and the public on the evolving trends and dynamics of the crypto market.

 

ABOUT INDEPENDENT RESERVE

Established in 2013, Independent Reserve is Australia’s trusted cryptocurrency exchange and OTC trading desk. Over 400,000 customers from Australia, New Zealand and Singapore trust Independent Reserve to easily trade Bitcoin, Ethereum, XRP and other major cryptocurrencies. Independent Reserve offers a range of innovative features, including AutoTrader, crypto OTC trading desk, API integration and world-class security.


Contact details:

Mark Eggleton

New Romans                         

0430 095 111 

More from this category

  • Finance Investment
  • 13/01/2026
  • 13:40
Moomoo

Focused on AI, Australian investors expect 2026 to deliver

SYDNEY, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Australian investors have started the new year with an overwhelming appetite for artificial intelligence and expectations of solid returns from their increasingly global portfolios, a comprehensive new survey by stock broking firm Moomoo Australia and New Zealand reveals.The detailed survey of more than 600 Australian investors' expectations and intentions for the year complements the release of moomoo's 2026 Market Outlook today, where our local experts and global research team analyse key trends in financial markets for the year ahead.And this year, investors are committing to high-growth sectors, including AI – showing a willingness…

  • Finance Investment, Oil Mining Resources
  • 13/01/2026
  • 10:22
Jane Morgan Management

Patriot Resources reports significant silver and gold results validating Kitumba polymetallic target in Zambia

Perth, Australia – 13 January 2026: Patriot Resources Limited (ASX: PAT) has reported significant silver and gold assay results from its Phase 1 trenching program at Target B1 within the Company’s 80%-owned Kitumba 27715 Project in Zambia, further validating the prospect as a near-surface polymetallic system. The latest results add silver and gold credits to previously announced strong copper, zinc and lead geochemistry, reinforcing the scale and potential economic significance of the mineralised system. The Company said the combination of metals highlights a unique polymetallic signature and strengthens confidence in Target B1 as a priority focus for ongoing exploration. Notable…

  • Contains:
  • Finance Investment, Medical Health Aged Care
  • 13/01/2026
  • 10:09
Jane Morgan Management

NeuroScientific Biopharmaceuticals (ASX:NSB) Reports Clinical Response for StemSmart(TM) Treatment in Fistulising Crohn’s Disease Under Special Access Program

13 January 2026 – Perth, Australia | NeuroScientific Biopharmaceuticals Limited (ASX:NSB) has today announced a “Clinical Response” from patients treated with its patented StemSmart™ Mesenchymal Stem Cell (MSC) therapy under the Therapeutic Goods Administration’s (TGA) Special Access Scheme (SAS) for fistulising Crohn’s disease. Three of four patients treated in Cohort 1 of the Special Access Program demonstrated a successful “Clinical Response” following treatment with StemSmart™, with the fourth patient showing a partial response with further clinical assessment needed. A Clinical Response is defined as either closure of at least 50 per cent of fistula openings or a reduction in fistula…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.